Herpes Simplex News and Research

RSS
Herpes simplex is a viral disease caused by herpes simplex viruses; both herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) cause herpes simplex. Infection with the herpes virus is categorized into one of several distinct disorders based on the site of infection.
Herpevac Trial for Women finds experimental vaccine ineffective in prevention of genital herpes disease

Herpevac Trial for Women finds experimental vaccine ineffective in prevention of genital herpes disease

Condoms can prevent transmission of herpes simplex virus 2: Study

Condoms can prevent transmission of herpes simplex virus 2: Study

FDA approves OZURDEX implant for uveitis treatment

FDA approves OZURDEX implant for uveitis treatment

Raltegravir could be valid target against all Herpesviridae

Raltegravir could be valid target against all Herpesviridae

Study: No association between first-trimester exposure to antiherpetic antiviral drugs and major birth defects

Study: No association between first-trimester exposure to antiherpetic antiviral drugs and major birth defects

NanoViricides' anti-Herpes drug candidates demonstrate significant efficacy in cell culture studies

NanoViricides' anti-Herpes drug candidates demonstrate significant efficacy in cell culture studies

NanoBio Corporation receives U.S. patent for nanoemulsion technology

NanoBio Corporation receives U.S. patent for nanoemulsion technology

Vical second-quarter revenues decrease to $2.1 million

Vical second-quarter revenues decrease to $2.1 million

DIATHERIX Laboratories opens rapid response diagnostic panels for STD, HSV

DIATHERIX Laboratories opens rapid response diagnostic panels for STD, HSV

Antigenics announces positive results of AG-707 genital herpes vaccine

Antigenics announces positive results of AG-707 genital herpes vaccine

Scientists discover mechanism of herpes virus cell entry machinery

Scientists discover mechanism of herpes virus cell entry machinery

Vical's prophylactic Vaxfectin-formulated pDNA vaccine effective against HSV-2 in animal model

Vical's prophylactic Vaxfectin-formulated pDNA vaccine effective against HSV-2 in animal model

Researchers make scientific breakthrough in fight against HIV, genital herpes with a vaginal gel

Researchers make scientific breakthrough in fight against HIV, genital herpes with a vaginal gel

Fatness drives inactivity, not the other way around

Fatness drives inactivity, not the other way around

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

FDA approves Beech Tree Labs' IND for Phase 1/2a clinical evaluation of BTL-TML-HSV

FDA approves Beech Tree Labs' IND for Phase 1/2a clinical evaluation of BTL-TML-HSV

Map of herpes virus "cell-entry machinery" provides new target for antiviral drugs

Map of herpes virus "cell-entry machinery" provides new target for antiviral drugs

LEAPS vaccine technology generates dendritic cells to stimulate immune system to fight viral illnesses

LEAPS vaccine technology generates dendritic cells to stimulate immune system to fight viral illnesses

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.